AACE Podcasts

Episode 73: Understanding Hypophosphatemia: Recognition, Diagnosis, and Treatment

Join Dr. Steven Petak, Past President of AACE and ISCD and former Chief of Endocrinology at Houston Methodist Hospital, as he leads an in-depth conversation on Hypophosphatemia with Dr. Laila Tabatabai, Associate Professor of Clinical Medicine at Weill Cornell and metabolic bone specialist at Houston Methodist, and Dr. Basma Abdulhadi, Assistant Professor of Medicine at the University of Alabama at Birmingham and head of bone densitometry. Together, they discuss how to distinguish Hypophosphatemia from osteoporosis and osteomalacia, recognize key symptoms across ages, and apply a focused diagnostic workup. The discussion also highlights FGF23-mediated disorders, XLH, and current treatment approaches including burosumab, reinforcing a key reminder for clinicians to check phosphate levels to help prevent missed diagnoses. This episode is made possible through a sponsorship from Kyowa Kirin. Kyowa Kirin was not involved in the content of the podcast.

Episode 72: Recognizing non-neoplastic hypercortisolism

Join Dr. Bahar Force, Endocrinologist, Medical Director of the Pituitary Center, and Associate Program Director of the Endocrinology Fellowship Program at Baylor College of Medicine, as she speaks with leading experts Dr. James Findling, Clinical Professor of Endocrinology at the Medical College of Wisconsin, and Dr. Ty Carroll, Visiting Professor of Endocrinology and Chief of the Division of Endocrinology, Diabetes and Metabolism at the University of Wisconsin Madison, for a clinician-focused conversation on non-neoplastic hypercortisolism. Together, they discuss how common conditions can lead to cortisol elevations that resemble Cushing syndrome, the clinical patterns that raise concern for neoplastic hypercortisolism, and the growing role of the Desmopressin Stimulation Test in helping distinguish between the two. The episode also highlights emerging research, including insights from the Catalyst study and the potential role of cortisol-directed therapy.

Episode 71: 2025 Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Based Chronic Disease Overview

Join endocrine expert Dr. David Lieb as he moderates a discussion with Dr. Karl Nadolsky, Chair of the AACE Obesity Algorithm, and Dr. Timothy Garvey, Vice Chair, as they review the 2025 AACE Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Based Chronic Disease and highlight key updates since 2016. The experts discuss advances in pharmacotherapy, the evolution of complication-centric and person-centered care, and strategies to reduce weight bias in clinical practice. They also share guidance on individualizing therapy and look ahead to the future of obesity medications as new treatments emerge.

Episode 70: 2025 Algorithm for Management of Adults with Dyslipidemia Update Overview

Join endocrine expert Dr. David Lieb as he moderates a discussion with Dr. Shailendra Patel, Chair of the 2025 AACE Dyslipidemia Algorithm; Dr. Maria Belalcazar, Vice Chair; and Dr. Robert Hegele, Author and Representative of the Canadian Cardiovascular Society, about the 2025 Updated Algorithm for Management of Adults with Dyslipidemia. This episode covers: * The rationale behind updating the algorithm and how it aligns with the 2025 Clinical Practice Guideline for the Pharmacologic Management of Adults with Dyslipidemia * Key updates from the 2020 algorithm, including expanded guidance on hypertriglyceridemia and lipid management in special populations * Practical strategies for integrating the algorithm into everyday clinical practice and medical education with an emphasis on patient-centered care, shared decision making, and health equity * Emerging therapies on the horizon and priority areas for future research   Tune in to hear expert insights on how this updated, evidence-based resource can support better clinical decision making and improve patient outcomes.

Episode 69: Expanding Access to Continuous Glucose Monitoring in Medicare Patients Receiving Specialty Diabetes Care: A Quality Improvement Project

Join Dr. Cecilia Lansang, Associate Editor of Endocrine Practice, Professor of Medicine, and Director of Endocrinology at Cleveland Clinic, as she speaks with Dr. Kristen Flint, Interim Director of Quality and Safety for Endocrinology at Massachusetts General Hospital, Attending Endocrinologist at MGH, and Instructor at Harvard Medical School, about her team’s quality improvement project, “Expanding Access to Continuous Glucose Monitoring in Medicare Patients Receiving Specialty Diabetes Care.”   This episode covers: * Strategies for implementing quality improvement interventions in a large academic diabetes specialty clinic * Key interventions that increased CGM utilization, including targeted provider education, workflow optimization, and patient outreach * Lessons for advancing equitable implementation and sustaining quality improvement over time   Tune in for practical insights on bridging policy changes and clinical practice to improve CGM access for Medicare patients. Read the full article in the August 2025 issue of Endocrine Practice here [https://secure-web.cisco.com/1t19WSnGcRixOffRSjgXK_iHjHnUeDdb4FCToB1FnOFMzSo0trIxgv0AyrVMxinC6681W9-mVCvCQ8nCZ9wWG46W1ezIVhiH-13LI_slyPZ9OSMtiB3Cjxla6dYYAMMAyV1aMf-lAL16zYKMwBpfuzoIq4jo19_lLII6WnKQq2pyctHSUBqinuFoBIbiMpKJDLNtR81DfcCWgMUjImqNiC-ItpGUO9SDrOnmE6dwovtGTTnPSHYce-N5yVB7pKfAa8X1digssHRE1vjus9Df2bkvTqhzj0M11lbY1iaVHNDTDlg-vgSEMIDzmOHfidiAG/https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1530891X25001053].